<DOC>
	<DOCNO>NCT01525771</DOCNO>
	<brief_summary>A maximum 8 cycle chemotherapy administer . Depending patient ' tolerability , 8 cycle chemotherapy give patient .</brief_summary>
	<brief_title>Safety Study Combined Systemic Intraperitoneal Chemotherapy Treat Stomach Cancer</brief_title>
	<detailed_description>Single-center , open-label , prospective , single-arm , phase I-II study About 37 patient ( Phase I 18 , Phase II 31 ( include 12 patient Phase I )</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . Unresectable metastatic advance gastric adenocarcinoma confirm histology 2 . Peritoneal seed proven histology cytology 3 . Completion adjuvant chemotherapy 6 month study , previous chemotherapy ( But , patient receive docetaxel cisplatin adjuvant chemotherapy exclude ) 4 . Age 18 70 year old 5 . Eastern Cooperative Oncology Group performance status &lt; _ 2 6 . Estimated life expectancy 3 month 7 . Adequate bone marrow function ( WBCs &gt; 3,000/µL absolute neutrophil count ( ANC ) &gt; 1,500/µL platelet &gt; 100,000/µL ) , 8 . Adequate renal function : creatinine &lt; 1 x upper normal limit ( UNL ) creatinine clearance _ &gt; 60ml/min 9 . Adequate hepatic function : bilirubin &lt; 1.5 x UNL , AST/ALT level &lt; 2.5 x UNL , alkaline phosphatase &lt; 5 x UNL ( except case bone metastasis without liver disease ) 10 . Written inform consent 1 . Contraindication drug contain chemotherapy regimen 2 . Other tumor type adenocarcinoma 3 . Presence history CNS metastasis 4 . Gastric outlet bowel obstruction 5 . Evidence serious gastrointestinal bleeding 6 . Peripheral neuropathy &gt; grade 2 7 . History significant neurologic psychiatric disorder 8 . History another malignancy within last five year except cure basal cell carcinoma skin cure carcinoma insitu uterine cervix 9 . Pregnant lactate woman , woman childbearing potential employ adequate contraception 10 . Other serious illness medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Advanced Gastric cancer</keyword>
	<keyword>Xeloda ( Capecitabine )</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Taxotere ( Docetaxel )</keyword>
</DOC>